Literature DB >> 15652508

AAV mediated expression of anti-sense neuropeptide Y cRNA in the arcuate nucleus of rats results in decreased weight gain and food intake.

J V Gardiner1, W M Kong, H Ward, K G Murphy, W S Dhillo, S R Bloom.   

Abstract

Neuropeptide Y (NPY) is the most potent stimulant of feeding when administered by intracerebroventricular injection. Despite this, there is conflicting evidence as to its importance in the regulation of daily food intake and energy balance. It has been suggested that whilst it is important in the response to starvation it has little role in the regulation of daily food intake. To investigate the role of NPY in the regulation of food intake, anti-sense cRNA to NPY was expressed in the arcuate nucleus of adult male rats. The anti-sense NPY (AS-NPY) construct was initially tested in vitro and there was a decrease of approximately 50% in NPY release from anti-sense treated cells compared to controls (16.3 +/- 2.0 fmol/L [AS-NPY] vs 37.3 +/- 7.7 fmol/L [control], mean +/- SEM p < 0.05). NPY release from hypothalamic explants from anti-sense injected animals was decreased by over 50% compared to those from controls at both 15 and 20 days after AAV injection (15 days 42% +/- 6.5% [AS-NPY] vs 100% +/- 36% [control], 20 days 41% +/- 6% [AS-NPY] vs 100% +/- 27% [control] mean+/-SEM, p < 0.05). In a study lasting for 50 days, weight gain was significantly lower in anti-sense injected animals from day 16 (day 16: 6.25 +/- 1.10 g [AS-NPY] vs 9.42 +/- 0.65 g [control] mean +/- SEM, p < 0.05) and remained so until the end of the study when they had gained approximately 40% less weight than controls (day 50: 52.0 +/- 9.6 g [AS-NPY] vs 82.0 +/- 6.3 g [control] mean +/- SEM, p < 0.01). Cumulative food intake was significantly lower in the anti-sense injected animals from day 23 (day 23: 225.8 +/- 1.9 g [AS-NPY] vs 250.6 +/- 8.7 g [control], mean +/- SEM, p < 0.05) and remained so until the end of the study (day 50: 834.5 +/- 14.8 g [AS-NPY] vs 926.0 +/- 31.7 g [control], mean +/- SEM, p < 0.05). Similarly mean daily food intake was also reduced in the anti-sense injected animals (days 7-14: 24.9 +/- 0.4 g/day [AS-NPY] vs 27.2 +/- 0.4 g/day [control], mean +/- SEM, p < 0.01). These data are supportive of a role for NPY in the regulation of daily food intake as well as in response to starvation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652508     DOI: 10.1016/j.bbrc.2004.12.113

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  To subjugate NPY is to improve the quality of life and live longer.

Authors:  Satya P Kalra; Pushpa S Kalra
Journal:  Peptides       Date:  2007-01-09       Impact factor: 3.750

Review 2.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 3.  A review on botanical species and chemical compounds with appetite suppressing properties for body weight control.

Authors:  Katie J Astell; Michael L Mathai; Xiao Q Su
Journal:  Plant Foods Hum Nutr       Date:  2013-09       Impact factor: 3.921

4.  NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways.

Authors:  Kristen R Vella; Preeti Ramadoss; Francis S Lam; Jamie C Harris; Felix D Ye; Paul D Same; Nicholas F O'Neill; Eleftheria Maratos-Flier; Anthony N Hollenberg
Journal:  Cell Metab       Date:  2011-11-17       Impact factor: 27.287

5.  Modulation of neuropeptide Y expression in adult mice does not affect feeding.

Authors:  Linda Ste Marie; Serge Luquet; Toby B Cole; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-08       Impact factor: 11.205

6.  Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity.

Authors:  Pei-Ting Chao; Liang Yang; Susan Aja; Timothy H Moran; Sheng Bi
Journal:  Cell Metab       Date:  2011-05-04       Impact factor: 27.287

7.  Glucokinase activity in the arcuate nucleus regulates glucose intake.

Authors:  Syed Hussain; Errol Richardson; Yue Ma; Christopher Holton; Ivan De Backer; Niki Buckley; Waljit Dhillo; Gavin Bewick; Shuai Zhang; David Carling; Steve Bloom; James Gardiner
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

8.  Cocaine and amphetamine-regulated transcript may regulate bone remodeling as a circulating molecule.

Authors:  Manvendra K Singh; Florent Elefteriou; Gerard Karsenty
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

9.  Role of dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance.

Authors:  Liang Yang; Karen A Scott; Jayson Hyun; Kellie L Tamashiro; Nancy Tray; Timothy H Moran; Sheng Bi
Journal:  J Neurosci       Date:  2009-01-07       Impact factor: 6.167

10.  Beneficial effects of hydro-alcoholic extract of Caralluma fimbriata against high-fat diet-induced insulin resistance and oxidative stress in Wistar male rats.

Authors:  G Sudhakara; P Mallaiah; N Sreenivasulu; B Sasi Bhusana Rao; R Rajendran; D Saralakumari
Journal:  J Physiol Biochem       Date:  2014-01-29       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.